Primary mediastinal B-cell lymphoma: High frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins

American Journal of Pathology

Volumn 162, Issue 1, 2003, Pages 243-253

  Pileri, Stefano A ^a   Gaidano, Gianluca ^b   Zinzani, Pier Luigi ^a   Falini, Brunangelo ^c   Gaulard, Philippe ^g   Zucca, Emanuele ^h   Pieri, Federica ^a   Berra, Eva ^b   Sabattini, Elena ^a   Ascani, Stefano ^a   Piccioli, Milena ^a   Johnson, Peter W M ⁱ   Giardini, Roberto ^d   Pescarmona, Edoardo ^e   Novero, Domenico ^f   Piccaluga, Pier Paolo ^a   Marafioti, Teresa ^a   Alonso, Miguel A ^j   Cavalli, Franco ^h  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g HENRI MONDOR HOSPITAL   (France)

^h OSPEDALE SAN GIOVANNI   (Switzerland)

ⁱ UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^j UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; CELL PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN; INTERFERON REGULATORY FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN MAL; SYNDECAN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BOB 1; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ARTICLE; CELL AGGREGATION; CELL SIZE; CONTROLLED STUDY; CYTOPLASM; GENE MUTATION; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; PRIMARY MEDIASTINAL B CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037222114     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63815-1     Document Type: Article

References (72)

1. Lichtenstein A, Levine A, Taylor CR, Boswell W, Rossamn S, Feinstein DI, Lukes RJ: Primary mediastinal lymphoma in adults. Am J Med 1980, 68:509-514
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994, 84:1316-1392
3. Jaffe ES, Harris NL, Stein H, Vardiman JW: Tumours of Haematopoietic and Lymphoid Tissues. Edited by ES Jaffe, NL Harris, H Stein, MJ Vardiman Lyon, IARC Press, 2001, pp 175-176
4. Addis BJ, Isaacson PG: Large cell lymphoma of the mediastinum: A B-cell tumor of probable thymic origin. Histopathology 1986, 10:379-390
5. Menestrina F, Chilosi M, Bonetti F, Lestani M, Scarpa A, Novelli P, Doglioni C, Todeschini G, Ambrosetti A, Fiore-Donati L: Mediastinal large-cell lymphoma of B-type, with sclerosis: Histopathological and immunohistochemical study of eight cases. Histopathology 1986, 10:589-600
6. Perrone T, Frizzera G, Rosai J: Mediastinal diffuse large cell lymphoma with sclerosis. Am J Surg Pathol 1986, 10:176-191
7. Isaacson PG, Norton AJ, Addis BJ: The human thymus contains a novel population of B lymphocytes. Lancet 1987, 2:1488-1491
8. Möller P, Moldenhauer G, Momburg F, Lammler B, Eberlein-Gonska M, Kiesel S, Dorken B: Mediastinal lymphoma of clear cell type is tumor corresponding to terminal steps of B-cell differentiation. Blood 1987, 59:1087-1095
9. Scarpa A, Bonetti F, Menestrina F, Chilosi M, Lestani M, Bovolenta C, Zamboni G, Fiore-Donati L: Mediastinal large cell lymphoma with sclerosis: Genotypic analysis establishes its B nature. Virchows Arch A Pathol Anat Histopathol 1987, 412:17-21
10. Aisenberg AC, Wilkes BM, Jacobson JO: The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 1988, 71:969-972
11. Hofmann WJ, Momburg F, Möller P: Thymic medullary cells expressing B lymphocyte antigens. Hum Pathol 1988, 19:1280-1287
12. Jacobson JO, Aisenberg AC, Lamarre L, Willett CG, Linggod RM, Miketic LM, Harris NL: Mediastinal large cell lymphoma: An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988, 62:1893-1898
13. Falini B, Pileri S, Martelli MF: Histological and immunohistological analysis of human lymphoma. Crit Rev Oncol Hematol 1989, 9:351-419
14. Lamarre L, Jacobson JO, Aisenberg AC, Harris NL: Primary large cell lymphoma of the mediastinum: A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 1989, 13:730-739
15. Huret JL, Brizard A, Babin P, Schoenwald M, Briault S, Guilhot F, Tanzer J: Translocation (8;9)(q12;p21): A new non-random rearrangement in lymphoid malignancies. Cancer Genet Cytogenet 1990, 45:125-129
16. Al-Sharabati M, Chittal S, Duga-Neulat I, Laurent G, Mazerolles C, Al-Saati T, Brousset P, Delsol G: Primary anterior mediastinal B-cell lymphoma. Cancer 1991, 67:2579-2587
17. Scarpa A, Borgato L, Chilosi M, Capelli P, Menestrina F, Bonetti F, Zamboni G, Pizzolo G, Hirohashi S, Fiore-Donati L: Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood 1991, 78:780-788
18. Eichelmann A, Koretz K, Mechtersheimer G, Möller P: Adhesion receptor profile of thymic B-cell lymphoma. Am J Pathol 1992, 141:729-741
19. Lavabre-Bertrand T, Donadio D, Fegueux N, Jessueld D, Taib J, Charlier D, Rousset T, Emberger JM, Baldet P, Navarro M: A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer 1992, 50:2561-2566
20. Lazzarino M, Orlandi E, Paulli M, Boveri E, Morra E, Brusolino E, Kindl S, Rosso R, Astori C, Buonanno MC: Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 1993, 11:2306-2313
21. Falini B, Venturi S, Martelli M, Santucci A, Pileri S, Pescarmona E, Giovannini M, Mazza P, Martelli MF, Pasqualucci L, Ballatori E, Guglielmi C, Amadori S, Poggi S, Sabattini E, Gherlinzoni F, Zinzani PL, Baroni CD, Mandelli F, Tura S: Mediastinal large B-cell lymphoma: Clinical and immunohistological findings in 18 patients treated with different third generation regimens. Br J Haematol 1995, 89:780-789
22. Kanavaros P, Gaulard P, Charlotte F, Martin N, Ducos C, Lebezu M, Mason DY: Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas. Am J Pathol 1995, 146:735-741
23. Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, Briere J, Blanc M, Gaulard P, Biron P, Schlaifer D, Diebold J, Ardouin J: Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas - A GELA ("Group d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 1996, 20:877-888
24. Joos S, Otano-Joos MI, Ziegler S, Bruderlein S, du Manoir S, Bentz M, Möller P, Lichter P: Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996, 87:1571-1578
25. Tsang P, Cesarman E, Chadburn A, Liu YF, Knowles DM: Molecular characterization of primary mediastinal B cell lymphoma. Am J Pathol 1996, 148:2017-2025
26. Paulli M, Strater J, Gianelli U, Rousset MT, Gambacorta M, Orlandi E, Klersy C, Lavabre-Bertrand T, Morra E, Manegold C, Lazzarino M, Magrini U, Möller P: Mediastinal B-cell lymphoma: A study of its histomorphologic spectrum based on 109 cases. Hum Pathol 1999, 30:178-187
27. Abou-Elella AA, Weisenburger DD, Vose JM, Kollath JP, Lynch JC, Bast MA, Bierman PJ, Greiner TC, Chan WC, Armitage JO: Primary mediastinal large B-cell lymphoma: A clinico-pathologic study of 43 patients from the Nebraska lymphoma study group. J Clin Oncol 1999, 17:784-790
28. Higgins JP, Warnke RA: CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 1999, 112:241-247
29. Copie-Bergman C, Gaulard P, Mauche-Chretien L, Briere J, Haioun C, Alonso MA, Romeo PH, Leroy K: The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood 1999, 94:3567-3575
30. Capello D, Vitolo U, Pasqualucci L, Quattrone S, Migliaretti G, Fassone L, Ariatti C, Vivenza D, Gloghini A, Pastore A, Lanza C, Nomdedeu J, Botto B, Freilone R, Bonaiuto D, Zagonel V, Gallo E, Palestro G, Saglio G, Dalla-Favera R, Carbone A, Gaidano G: Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000, 95:651-659
31. Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi S, Piccioli M, Piccaluga PP, Gamberi B, Zinzani PL, Leoncini L, Falini B: The pathologist's view point: Part II - Aggressive lymphomas. Haematologica 2000, 85:1285-1298
32. Van Besien K, Kelta M, Bahaguna P: Primary mediastinal B-cell lymphoma: A review of pathology and management. J Clin Oncol 2001, 19:1855-1864
33. Riguad G, Moore PS, Taruscio D, Scardoni M, Montresor M, Menestrina F, Scarpa A: Alterations of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping. Genes Chromosom Cancer 2001, 31:191-195
34. De Leval L, Ferry JA, Falini B, Shipp M, Harris NL: Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma. Am J Surg Pathol 2001, 25:1277-1282
35. Laithäuser F, Bäuerle M, Huynh MQ, Möller P: Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma. Blood 2001, 98:2762-2770
36. Palanisamy N, Abou-Elella AA, Chaganti SR, Houldworth J, Offit K, Louie DC, Terayu-Feldstein J, Cigudosa JC, Rao PH, Sanger WG, Weisenburger DD, Chaganti RS: Similar patterns of genetic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosom Cancer 2002, 33:114-122
37. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye BH, Gambacorta M, Pacini R, Baroni CD, Pescarmona E, Anagnostopoulos, Stein H, Asdrubali G, Martelli MF, Pelicci PG, Dalla-Favera R, Falini B: Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 1996, 148:1543-1553
38. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K, Dalla-Favera R: BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 1998, 95:11816-11821
39. Shen HM, Peters A, Baron B, Zhu X, Storb U: Mutations of BCL-6 in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998, 280:1750-1752
40. Kuppers R, Klein U, Hansmann ML, Rajewsky K: Cellular origin of human B-cell lymphomas. N Engl J Med 1999, 341:1520-1529
41. Gaidano G, Carbone A: MUM-1: A step ahead toward the understanding of lymphoma histogenesis. Leukemia 2000, 4:1209-1215
42. Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, Pacini R, Alunni C, Natali-Tanci L, Ugolini B, Sebastiani C, Cattoretti G, Pileri S, Dalla-Favera R, Stein H: A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF-4 protein in a subset of germinal center B cells, plasma cells and activated T-cells. Blood 2000, 95:2084-2092
43. Alonso MA, Barton DE, Francke U: Assignment of the T cell differentiation gene MAL to human chromosome 2, region cen-q13. Immunogenetics 1988, 27:91-95
44. Millán J, Alonso MA: MAL, a novel integral membrane protein of human T lymphocytes, associates with glycosylphosphatidylinositolanchored proteins and Src-like tyrosine kinases. Eur J Immunol 1998, 28:3675-3684
45. Alonso MA, Millán J: The role of lipid rafts in signaling and membrane trafficking in T lymphocytes. J Cell Sci 2001, 114:3957-3965
46. Millan J, Montoya MC, Sancho D, Sánchez-Madrid F, Alonso MA: Lipid rafts mediate biosynthetic transport to the T cell uropod subdomain and are necessary for uropod integrity and function. Blood 2002, 99:978-984
47. Pileri S, Falini B, Sabattini E, Bigerna B, Gherlinzoni F, Tazzari PL: Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections. Haematologica 1991, 76:226-234
48. Pileri SA, Sabattini E: A rational approach to immunohistochemical analysis of malignant lymphomas on paraffin wax sections. J Clin Pathol 1997, 50:2-4
49. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA: Envision Plus: A new immunohistochemical method of choice for diagnostics and research. Critical comparison with the APAAP, ChemMate CSA, LABC, and SABC techniques. J Clin Pathol 1998, 51:506-511
50. Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B: Antigen retrieval techniques in immunohistochemistry: Comparison of different methods. J Pathol 1997, 183:116-123
51. Kuppers R, Rajewsky K, Hansmann M-L: Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol 1997, 27:1398-1405
52. Fais F, Gaidano G, Capello D, Gloghini A, Ghiotto F, Roncella S, Carbone A, Chiorazzi N, Ferrarini M: Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphoma. Leukemia 1999, 13:1093-1099
53. Kaplan EL, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-481
54. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SW, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977, 35:1-39
55. Cox DR: Regression models and life-tables (with discussion). J Royal Statist Soc 1972, 34:187-220
56. Jundt F, Kley K, Anagnostopoulos I, Schulze Pröbsting K, Greiner A, Mathas S, Scheidereit C, Wirth T, Stein H, Dörken B: Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 2002, 99:3060-3062
57. Copie-Bergman C, Plonquet A, Alonso M, Boulland ML, Marquet J, Divine M, Möller P, Leroy K, Gaulard P: MAL expression in lymphoid cells: Further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. J Clin Pathol 2002, 55(Suppl 1):A16
58. Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995, 85:1-14
59. Lamarre L, Jacobson JO, Aisenberg AC, Harris NL: Primary large cell lymphoma of the mediastinum: A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 1989, 13:730-739
60. Rodriguez J, Pugh WC, Romaguera JE, Cabanillas F: Primary mediastinal large cell lymphoma. Hematol Oncol 1994, 94:175-192
61. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, Jaffe E, Ralfkiaer E, Dallenbach F, Stein H, Pileri S, Gatter KC: CD79a: A novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995, 86:1453-1459
62. Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P: B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 1996, 383:538-542
63. Qin XF, Reichlin A, Luo Y, Roeder RG, Nussenzweig MC: OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J 1998, 17:5066-5075
64. Re D, Muschen M, Ahmadi T, Wickenhauser C, Staratschek-Jox A, Holtick U, Diehl V, Wolf J: Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. Cancer Res 2001, 61:2080-2084
65. Stein H, Marafioti T, Foss HD, Laumen H, Hummel M, Anagnostopoulos I, Wirth T, Demel G, Falini B: Down-regulation of BOB. 1/OBF. 1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001, 97:496-501
66. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to ets oncogene. Cell 1990, 61:113-124
67. Henderson A, Calame K: Transcriptional regulation during B cell development. Annu Rev Immunol 1998, 16:163-200
68. DeKoter RP, Singh H: Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000, 288:1439-1441
69. Schwarzenbach H, Newell JW, Matthias P: Involvement of Ets family factor PU.1 in the activation of immunoglobulin promoters. J Biol Chem 1993, 27:898-907
70. Sahota SS, Davs Z, Hamblin TJ, Stevenson FK: Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia. Blood 2000, 95:3534-3540
71. Pileri S, Rivano MT, Raise E, Gualandi G, Gobbi M, Martuzzi M, Gritti FM, Gerdes J, Stein H: The value of lymph node biopsy in patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex (ARC): A morphological and immunohistochemical study of 90 cases. Histopathology 1986, 10:1107-1129
72. Knowles D: Neoplastic Hematopathology. Edited by DM Knowles. Philadelphia, Williams & Wilkins, 2001, pp 263-298